Keith A Bostian

Title: The Innovations of Keith A. Bostian

Introduction

Keith A. Bostian is an accomplished inventor based in Westfield, NJ (US). He has made significant contributions to the field of immunology through his innovative work with yeast mutants. His research has the potential to impact the identification of immunosuppressants, which are crucial in various medical treatments.

Latest Patents

Bostian holds a patent for "Yeast mutants useful for identifying immunosuppressants." This patent discloses a process that utilizes yeast mutants for identifying active FK-506 type immunosuppressants. The process involves Saccharomyces cerevisiae mutants containing an fkr1, fkr2, fkr3 mutant gene or a mixture thereof, which are resistant to FK-506 but sensitive to rapamycin. These mutants can be employed in diagnostic procedures for identifying FK-506 and FK-506 type immunosuppressants, as well as in screening assays for compounds and fermentation broths exhibiting FK-506 type immunosuppressive activity. Specifically, the new yeast mutants include Saccharomyces cerevisiae YKF093, (Merck Culture Collection No. MY 2088) ATCC No. 74055, containing an fkr3 mutant gene, Saccharomyces cerevisiae YKF 012, (Merck Culture Collection No. MY 2096) ATCC No. 74061, which contains an fkr1 mutant gene, and Saccharomyces cerevisiae YFK 014, (Merck Culture Collection No. MY 2097) ATCC No. 74062, along with YFK-023-17A (Merck Culture Collection No. MY 2098) ATCC No. 74063, both containing an fkr2 mutant gene.

Career Highlights

Bostian is currently associated with Merck & Co., Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on groundbreaking research that bridges the gap between microbiology and immunology. His patent reflects his dedication to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Bostian has collaborated with notable colleagues, including Stephen Authur Parent and Leonardo E. Brizuela. These collaborations have fostered an environment of innovation and have contributed to the success of his research endeavors.